CRSP
Price
$35.62
Change
-$0.52 (-1.44%)
Updated
May 9 closing price
Capitalization
3.08B
92 days until earnings call
RLAY
Price
$3.00
Change
-$0.00 (-0.00%)
Updated
May 9 closing price
Capitalization
514.33M
93 days until earnings call
Ad is loading...

CRSP vs RLAY

Header iconCRSP vs RLAY Comparison
Open Charts CRSP vs RLAYBanner chart's image
CRISPR Therapeutics AG
Price$35.62
Change-$0.52 (-1.44%)
Volume$1.74M
Capitalization3.08B
Relay Therapeutics
Price$3.00
Change-$0.00 (-0.00%)
Volume$2.91M
Capitalization514.33M
CRSP vs RLAY Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. RLAY commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and RLAY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (CRSP: $35.62 vs. RLAY: $3.00)
Brand notoriety: CRSP and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 85% vs. RLAY: 102%
Market capitalization -- CRSP: $3.08B vs. RLAY: $514.33M
CRSP [@Biotechnology] is valued at $3.08B. RLAY’s [@Biotechnology] market capitalization is $514.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 8 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 4 bearish.
  • RLAY’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а -6.88% price change this week, while RLAY (@Biotechnology) price change was -7.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

RLAY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.08B) has a higher market cap than RLAY($514M). CRSP YTD gains are higher at: -9.502 vs. RLAY (-27.184). RLAY has higher annual earnings (EBITDA): -380.21M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. RLAY (781M). RLAY has less debt than CRSP: RLAY (48.5M) vs CRSP (224M). CRSP has higher revenues than RLAY: CRSP (35M) vs RLAY (10M).
CRSPRLAYCRSP / RLAY
Capitalization3.08B514M598%
EBITDA-447.31M-380.21M118%
Gain YTD-9.502-27.18435%
P/E RatioN/AN/A-
Revenue35M10M350%
Total Cash1.9B781M244%
Total Debt224M48.5M462%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPRLAY
RSI
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 5 days ago
73%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BFTIX55.050.26
+0.47%
Baron Fifth Avenue Growth Instl
WRLDX36.740.13
+0.36%
Scharf Global Opportunity Institutional
QAACX44.62-0.03
-0.07%
Federated Hermes MDT All Cap Core A
IYGIX38.24-0.08
-0.21%
Macquarie Large Cap Growth Fund I
ILGJX20.38-0.08
-0.39%
Columbia Integrated Large Cap Gr Ins 3

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-1.44%
RXRX - CRSP
72%
Closely correlated
-1.37%
BEAM - CRSP
71%
Closely correlated
+0.93%
NTLA - CRSP
67%
Closely correlated
-1.93%
PRME - CRSP
63%
Loosely correlated
-1.52%
ABCL - CRSP
62%
Loosely correlated
+1.00%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
N/A
XNCR - RLAY
49%
Loosely correlated
-5.23%
BCYC - RLAY
47%
Loosely correlated
+1.96%
IMNM - RLAY
45%
Loosely correlated
-3.24%
RXRX - RLAY
45%
Loosely correlated
-1.37%
BDTX - RLAY
45%
Loosely correlated
-2.96%
More